Geneva, Aug. 17 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129724) titled 'A prospective, multicenter, randomized controlled clinical study of Rui Anning versus OxyContin for the treatment of moderate-to-severe cancer pain' on Aug. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Friendship Hospital, Capital Medical University
Condition:
moderate-to-severe cancer pain
Intervention:
Experimental group:Take Rui Anning (Oxycodone Hydrochloride Extended-Release Tablets)
Recruitment Status: Recruiting
Phase: 4
Date of First Enrollment: 2024-03-19
Target Sample Size: Experimental group:125;Control group:125;
Countries of Recruitment:
China
T...